BioTelemetry's Total Assets for the quarter that ended in Sep. 2020 was $737.1 Mil.
Warning Sign:
If a company builds asset at 51.9% a year, faster than its revenue growth rate of 16.6% over the past 5 years, it means that the company may be getting less efficent.
During the past 12 months, BioTelemetry's average Total Assets Growth Rate was 5.30% per year.
During the past 3 years, the average Total Assets Growth Rate was 51.90% per year.
During the past 5 years, the average Total Assets Growth Rate was 51.90% per year.
During the past 10 years, the average Total Assets Growth Rate was 23.80% per year.
During the past 13 years, BioTelemetry's highest 3-Year average Total Assets Growth Rate was 107.90%. The lowest was -23.30%. And the median was 29.10%.
The historical data trend for BioTelemetry's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
BioTelemetry's Total Assets for the fiscal year that ended in Dec. 2019 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Sep. 2020) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
BioTelemetry's Asset Turnover for the quarter that ended in Sep. 2020 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
BioTelemetry Total Assets Related Terms
Thank you for viewing the detailed overview of BioTelemetry's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BEAT has been successfully added to your 